Global OTC Drug Market Research Report 2020 by Manufacturers, Regions, Types and Applications

Table of Contents

1 Report Overview

• 1.1 Definition
• 1.2 Manufacturers and Regions Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
• 1.3 Type Overview
• 1.4 Application Overview
• 1.5 Industrial Chain
  • 1.5.1 OTC Drug Overall Industrial Chain
  • 1.5.2 Upstream
  • 1.5.3 Downstream
  • 1.5.4 Economic/Political Environment

2 Global OTC Drug Market Assesment by Types

• 2.1 Overall Market Performance
  • 2.1.1 Product Type Market Performance (Volume)
  • 2.1.2 Product Type Market Performance (Value)
• 2.2 China OTC Drug Market Performance
• 2.3 USA OTC Drug Market Performance
• 2.4 Europe OTC Drug Market Performance
• 2.5 Japan OTC Drug Market Performance
• 2.6 Korea OTC Drug Market Performance
• 2.7 India OTC Drug Market Performance
• 2.8 Southeast Asia OTC Drug Market Performance
• 2.9 South America OTC Drug Market Performance

3 Global OTC Drug Market Assesment by Application

• 3.1 Overall Market Performance (Volume)
• 3.2 China OTC Drug Market Performance (Volume)
• 3.3 USA OTC Drug Market Performance (Volume)
• 3.4 Europe OTC Drug Market Performance (Volume)
• 3.5 Japan OTC Drug Market Performance (Volume)
• 3.6 Korea OTC Drug Market Performance (Volume)
• 3.7 India OTC Drug Market Performance (Volume)
• 3.8 Southeast Asia OTC Drug Market Performance (Volume)
• 3.9 South America OTC Drug Market Performance (Volume)

4 Competitive Analysis

• 4.1 Bayer HealthCare
  • 4.1.1 Bayer HealthCare Profiles
  • 4.1.2 Bayer HealthCare Product Information
  • 4.1.3 Bayer HealthCare OTC Drug Production, Revenue, Price and Gross Margin
  • 4.1.4 Bayer HealthCare OTC Drug Business Performance
  • 4.1.5 SWOT Analysis
• 4.2 GlaxoSmithKline (GSK)
  • 4.2.1 GlaxoSmithKline (GSK) Profiles
  • 4.2.2 GlaxoSmithKline (GSK) Product Information
  • 4.2.3 GlaxoSmithKline (GSK) OTC Drug Production, Revenue, Price and Gross Margin
  • 4.2.4 GlaxoSmithKline (GSK) OTC Drug Business Performance
  • 4.2.5 SWOT Analysis
• 4.3 Johnson&Johnson
  • 4.3.1 Johnson&Johnson Profiles
  • 4.3.2 Johnson&Johnson Product Information
  • 4.3.3 Johnson&Johnson OTC Drug Production, Revenue, Price and Gross Margin
  • 4.3.4 Johnson&Johnson OTC Drug Business Performance
  • 4.3.5 SWOT Analysis
• 4.4 Pfizer
  • 4.4.1 Pfizer Profiles
  • 4.4.2 Pfizer Product Information
  • 4.4.3 Pfizer OTC Drug Production, Revenue, Price and Gross Margin
  • 4.4.4 Pfizer OTC Drug Business Performance
  • 4.4.5 SWOT Analysis
• 4.5 Sanofi
  • 4.5.1 Sanofi Profiles
  • 4.5.2 Sanofi Product Information
  • 4.5.3 Sanofi OTC Drug Production, Revenue, Price and Gross Margin
  • 4.5.4 Sanofi OTC Drug Business Performance
  • 4.5.5 SWOT Analysis
• 4.6 AstraZeneca
  • 4.6.1 AstraZeneca Profiles
  • 4.6.2 AstraZeneca Product Information
  • 4.6.3 AstraZeneca OTC Drug Production, Revenue, Price and Gross Margin
  • 4.6.4 AstraZeneca OTC Drug Business Performance
  • 4.6.5 SWOT Analysis
• 4.7 BioGaia
  • 4.7.1 BioGaia Profiles
  • 4.7.2 BioGaia Product Information
  • 4.7.3 BioGaia OTC Drug Production, Revenue, Price and Gross Margin
  • 4.7.4 BioGaia OTC Drug Business Performance
  • 4.7.5 SWOT Analysis
• 4.8 Bristol Myers Squibb
  • 4.8.1 Bristol Myers Squibb Profiles
  • 4.8.2 Bristol Myers Squibb Product Information
  • 4.8.3 Bristol Myers Squibb OTC Drug Production, Revenue, Price and Gross Margin
  • 4.8.4 Bristol Myers Squibb OTC Drug Business Performance
  • 4.8.5 SWOT Analysis
• 4.9 Bukwang Pharmaceutica
  • 4.9.1 Bukwang Pharmaceutica Profiles
  • 4.9.2 Bukwang Pharmaceutica Product Information
  • 4.9.3 Bukwang Pharmaceutica OTC Drug Production, Revenue, Price and Gross Margin
  • 4.9.4 Bukwang Pharmaceutica OTC Drug Business Performance
  • 4.9.5 SWOT Analysis
• 4.10 Chr. Hansen
  • 4.10.1 Chr. Hansen Profiles
  • 4.10.2 Chr. Hansen Product Information
  • 4.10.3 Chr. Hansen OTC Drug Production, Revenue, Price and Gross Margin
  • 4.10.4 Chr. Hansen OTC Drug Business Performance
  • 4.10.5 SWOT Analysis
• 4.11 Cipla
• 4.12 CoLucid
• 4.13 Daiichi Sankyo
• 4.14 Friggs
• 4.15 DSM
• 4.16 Eisai
• 4.17 Eli Lilly
• 4.18 Herbalife
• 4.19 Euradite

5 Competitive Landscape

• 5.1 Global OTC Drug Production (K Units) and Market Share by Manufacturers (2014-2020)
• 5.2 Global OTC Drug Revenue (M USD) and Market Share by Manufacturers (2014-2020)
• 5.3 Global OTC Drug Price (USD/Unit) of Manufacturers (2014-2020)
• 5.4 Global OTC Drug Gross Margin of Manufacturers (2014-2020)
• 5.5 Market Concentration

6 Global OTC Drug Market Assessment by Regions

• 6.1 Global OTC Drug Production (K Units) and Market Share by Regions (2014-2020)
• 6.2 Global OTC Drug Revenue (M USD) and Market Share by Regions (2014-2020)
• 6.3 Global OTC Drug Price (USD/Unit) by Regions (2014-2020)
• 6.4 Global OTC Drug Gross Margin by Regions (2014-2020)

7 OTC Drug Regional Analysis

• 7.1 China OTC Drug Production, Revenue and Growth Rate (2014-2020)
• 7.2 USA OTC Drug Production, Revenue and Growth Rate (2014-2020)
• 7.3 Europe OTC Drug Production, Revenue and Growth Rate (2014-2020)
• 7.4 Japan OTC Drug Production, Revenue and Growth Rate (2014-2020)
• 7.5 Korea OTC Drug Production, Revenue and Growth Rate (2014-2020)
• 7.6 India OTC Drug Production, Revenue and Growth Rate (2014-2020)
• 7.7 Southeast Asia OTC Drug Production, Revenue and Growth Rate (2014-2020)
• 7.8 South America OTC Drug Production, Revenue and Growth Rate (2014-2020)

8 Global OTC Drug Consumption Assessment

• 8.1 Global OTC Drug Consumption and Market Share by Regions (2014-2020)
• 8.2 Global OTC Drug Consumption Value and Market Share by Regions (2014-2020)
• 8.3 Global OTC Drug Average Price (USD/Unit) by Regions (2014-2020)

9 Global OTC Drug Sales Assessment by Regions

• 9.1 Global OTC Drug Sales and Sales Value (2014-2020)
• 9.2 China OTC Drug Sales and Sales Value (2014-2020)
• 9.3 USA OTC Drug Sales and Sales Value (2014-2020)
• 9.4 Europe OTC Drug Sales and Sales Value (2014-2020)
• 9.5 Japan OTC Drug Sales and Sales Value (2014-2020)
• 9.6 Korea OTC Drug Sales and Sales Value (2014-2020)
• 9.7 India OTC Drug Sales and Sales Value (2014-2020)
• 9.8 Southeast Asia OTC Drug Sales and Sales Value (2014-2020)
• 9.9 South America OTC Drug Sales and Sales Value (2014-2020)

10 Technology and Cost

• 10.1 Technology
• 10.2 Cost

11 Channel Analysis

• 11.1 Market Channel
• 11.2 Distributors

12 Market Forecast 2021-2026

• 12.1 Production and Revenue Forecast 2021-2026
  • 12.1.1 Global OTC Drug Production and Revenue by Regions 2021-2026
  • 12.1.2 China OTC Drug Production, Revenue and Growth Rate 2021-2026
  • 12.1.3 USA OTC Drug Production, Revenue and Growth Rate 2021-2026
  • 12.1.4 Europe OTC Drug Production, Revenue and Growth Rate 2021-2026
  • 12.1.5 Japan OTC Drug Production, Revenue and Growth Rate 2021-2026
  • 12.1.6 Korea OTC Drug Production, Revenue and Growth Rate 2021-2026
  • 12.1.7 India OTC Drug Production, Revenue and Growth Rate 2021-2026
  • 12.1.8 Southeast Asia OTC Drug Production, Revenue and Growth Rate 2021-2026
  • 12.1.9 South America OTC Drug Production, Revenue and Growth Rate 2021-2026
• 12.2 Sales and Sales Value Forecast 2021-2026
  • 12.2.1 Global OTC Drug Consumption and Consumption Calue by Regions 2021-2026
  • 12.2.2 Global OTC Drug Sales and Sales Value Forecast 2021-2026
  • 12.2.3 China OTC Drug Sales, Sales Value and Growth Rate 2021-2026
  • 12.2.4 USA OTC Drug Sales and Sales Value Forecast 2021-2026
  • 12.2.5 Europe OTC Drug Sales and Sales Value Forecast 2021-2026
  • 12.2.6 Japan OTC Drug Sales and Sales Value Forecast 2021-2026
  • 12.2.7 Korea OTC Drug Sales and Sales Value Forecast 2021-2026
  • 12.2.8 India OTC Drug Sales and Sales Value Forecast 2021-2026
  • 12.2.9 Southeast Asia OTC Drug Sales and Sales Value Forecast 2021-2026
  • 12.2.10 South America OTC Drug Sales and Sales Value Forecast 2021-2026
• 12.3 Global OTC Drug Production and Revenue Forecast by Type 2021-2026
  • 12.3.1 Overall Market Performance
  • 12.3.2 Class A
  • 12.3.3 Class B
• 12.4 Global OTC Drug Sales Forecast by Application 2021-2026
  • 12.4.1 Overall Market Performance
  • 12.4.2 Hospital
  • 12.4.3 Clinic
  • 12.4.4 Household
• 12.5 Global OTC Drug Price and Gross Margin Forecast
  • 13.5.1 Global OTC Drug Averages Price Development Trend Forecast 2021-2026
  • 13.5.2 Global OTC Drug Gross Margin Development Trend Forecast 2021-2026

13 Conclusion